The most telling development in D-Wave Quantum’s recent history wasn’t announced by the company itself. It surfaced in a regulatory filing: Manufacturers Life Insurance Company acquired 204,727 shares on Tuesday, a roughly $4.9 million wager placed squarely against the prevailing mood among retail investors.
That institutional vote of confidence lands at an awkward moment for the quantum computing firm. The share price closed Friday at €14.30, down 1.1 percent on the day, and has shed 23 percent over the past month. Since the start of the year, the decline stretches to 37 percent. The stock now trades 65 percent below its October 15 peak of €40.41, and sits 15 percent beneath its 50-day moving average of €16.80 — a technical configuration that offers little comfort to momentum traders.
A Leadership Vacuum at the Top
The immediate source of investor anxiety traces back to the announcement last Wednesday that CFO John Markovich would step down effective September 2, ending a five-year tenure. D-Wave was quick to clarify that his departure bore no connection to disagreements over management, accounting practices, or internal controls. Greg Golkov, previously Senior Vice President of Finance, assumes the role of interim finance chief and principal accounting officer.
The governance turbulence doesn’t end there. The board appointment of Kevan P. Krysler roughly three weeks ago has done nothing to steady the ship — the stock has lost 21.8 percent since that announcement. Add to that a round of disappointing quarterly results delivered about a month ago, and the picture becomes clearer: a company whose operational narrative and market narrative have drifted far apart.
Insider activity tells a similar story. Sophie C. Ames, the chief people officer, sold 23,850 shares on August 17. The SEC filing accompanying that transaction framed the sale as purely tax-related, tied to the vesting of restricted stock units, with no implication of changed conviction about the company’s prospects.
The Bull Case Hiding in Plain Sight
Strip away the personnel drama, though, and a different D-Wave emerges — one that has been quietly converting its technological promise into commercial traction. The second quarter saw commercial customers account for 62.4 percent of revenue, a milestone that marks a decisive shift away from the research organizations that once dominated the customer mix.
The bookings pipeline tells an even more striking story. First-half bookings surged 1,120 percent year over year, propelled by a $20 million system contract with Florida Atlantic University. The backlog of unfulfilled orders now stands at $40.7 million, with 57 percent of that sum expected to convert into recognized revenue within twelve months.
Should investors sell immediately? Or is it worth buying D-Wave Quantum?
Product development continues apace as well. Next month, D-Wave plans to launch a new simulator on its Leap cloud platform, part of expanded quantum development packages. The tool supports up to 21 qubits, offers both ideal and hardware-near emulation modes, and includes Monte-Carlo simulations of real quantum system dynamics. Crucially, it integrates with the company’s own Ocean SDK — a deliberate strategy to lock developers into the ecosystem before they become paying customers.
Washington, Wall Street, and the Long Game
The company has also been building bridges beyond the commercial sphere. In January, D-Wave announced a two-year QCaaS contract worth $10 million with a Fortune 100 company. May brought a letter of intent for up to $100 million in potential CHIPS Act funding. And the IDC MarketScape’s 2026 assessment of the global quantum computing landscape named D-Wave a “Leader” — one of only two companies to earn that distinction.
These developments all predate the CFO’s exit, yet they explain why an institution like Manufacturers Life might view the current share price as an entry point rather than an exit signal. Institutional investors tend to underwrite cycles, not quarters. Quantum computing is a technology measured in customer contracts, funding commitments, and industry rankings — categories where D-Wave has made demonstrable progress regardless of its executive bench strength.
The Risks That Remain
None of this absolves the stock of its immediate problems. The 200-day moving average sits 24 percent above the current price, and the 50-day average is 15 percent higher — both pointing to a downtrend that won’t reverse overnight. The annualized volatility of 89 percent underscores just how jittery the market remains about this name. A relative strength index of 39.4 suggests weak buying pressure rather than a classic oversold condition.
The next real test arrives November 5, when D-Wave publishes its quarterly results. Between now and then, the market will be watching whether the new simulator and the commercial customer push can translate into the kind of recurring revenue that would justify the institutional optimism. The insurance company’s purchase is evidence, not proof — a signal that at least one sophisticated investor reads the recent weakness as opportunity rather than warning. Whether that interpretation wins the day depends less on who occupies the CFO office than on whether letters of intent and pilot contracts mature into dependable income streams.
Ad
D-Wave Quantum Stock: Buy or Sell?! New D-Wave Quantum Analysis from September 6 delivers the answer:
The latest D-Wave Quantum figures speak for themselves: Urgent action needed for D-Wave Quantum investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from September 6.
D-Wave Quantum: Buy or sell? Read more here...
